Advertisement

Topics

2 sites added for Trovagene's early-stage leukemia candidate trial

04:56 EST 15 Feb 2018 | SmartBrief

Trovagene added two sites to the Phase Ib/II study evaluating the efficacy of its drug candidate PCM-075 in patients with acu -More

Original Article: 2 sites added for Trovagene's early-stage leukemia candidate trial

NEXT ARTICLE

More From BioPortfolio on "2 sites added for Trovagene's early-stage leukemia candidate trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...